Fresh Recalls

Duloxetine Delayed-Release Capsules: recall status

⚠ Recalls found. Duloxetine Delayed-Release Capsules is named in 2 official recalls in our current data:

Brand
Breckenridge Pharmaceutical

Recalls naming this model

FDA Class II · Drug · June 17, 2026

Duloxetine Delayed-Release Capsules recall — Breckenridge Pharmaceutical, Inc.

CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit

Company / brand: Breckenridge Pharmaceutical

Affected product: Duloxetine Delayed-Release Capsules

Official ID D-0582-2026 · Official record ↗

FDA Class II · Drug · June 17, 2026

Duloxetine Delayed-Release Capsules recall — Breckenridge Pharmaceutical, Inc.

CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit

Company / brand: Breckenridge Pharmaceutical

Affected product: Duloxetine Delayed-Release Capsules

Official ID D-0583-2026 · Official record ↗

See all Breckenridge Pharmaceutical recalls →

Verify with the official sources:

Found something wrong or missing? Report a data error.

Compiled from connected official public-domain government data. Sources last checked September 7, 2026 at 6:00 AM UTC.